title: Zidovudine prophylaxis and perinatal HIV-1 transmission.
authors.forename: G V
authors.initials: GV
authors.lastname: Zuccotti
authors.forename: G
authors.initials: G
authors.lastname: Ferraris
authors.forename: C
authors.initials: C
authors.lastname: Agostoni
authors.forename: L
authors.initials: L
authors.lastname: Rancilio
authors.forename: M
authors.initials: M
authors.lastname: Ravizza
authors.forename: A M
authors.initials: AM
authors.lastname: Bucceri
authors.forename: E
authors.initials: E
authors.lastname: Riva
authors.forename: A
authors.initials: A
authors.lastname: Marini
mesh_terms: D000284:Administration, Oral; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D005260:Female; D005865:Gestational Age; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007275:Injections, Intravenous; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011446:Prospective Studies; D016896:Treatment Outcome; D015215:Zidovudine / Q000008:administration & dosage*
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine